Clinical trials: Pelvic Congestion Syndrome
Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Prostatitis
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
This study is planned to Evaluate the Efficacy and Safety of OM-89 in Patients with Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
- Conditions
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Prostatitis, Chronic Pelvic Pain Syndrome
- Trial name
- NCT06345014
- Testing
- OM-89 [Uro-Vaxom® Capsule]
- Where
- South Korea
- Volunteers
- 332 people
- Sponsor
- AJU Pharm Co., Ltd.
Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
The primary objective is to compare the efficacy of silodosin 4 and 8 mg once daily with placebo in the treatment of subjects with moderate to severe abacterial chronic prostatitis/chronic pelvic pain syndrome during a 12 week…
- Trial name
- NCT00740779
- Testing
- Silodosin 8 mg, Silodosin 4 mg
- Where
- 22 sites in United States
- Volunteers
- 153 people
- Sponsor
- Watson Pharmaceuticals
Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Erectile Dysfunction
Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction
Objective: The purpose of this study was to evaluate the clinical efficacy and safety of Ningmitai capsule alone or in combination with sildenafil compared with sildenafil alone in the treatment of CP/CPPS with erectile…
- Trial name
- NCT06064448
- Testing
- Sildenafil, Ningmitai capsule, Ningbitai capsule + sildenafil
- Where
- China
- Volunteers
- 254 people
- Sponsor
- Xintian Pharmaceutical
Chronic Prostatitis
Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
1. Clinical trial title：Efficacy and safety of Ningmitai capsule in patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome：A prospective, randomized, positive drug-controlled, multicenter clinical study 2.
- Trial name
- NCT05890235
- Testing
- Ningmitai Capsule, Tamsulosin Hydrochloride
- Where
- China
- Volunteers
- 323 people
- Sponsor
- Xintian Pharmaceutical
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for the Treatment of Symptoms Associated With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
The goal of this clinical trial is to evaluate whether a medical device is effective and safe in treating chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in adult men.
- Trial name
- NCT07685847
- Testing
- Prospidol suppository
- Where
- 2 sites in Italy
- Volunteers
- 40 people
- Sponsor
- S&R Farmaceutici S.p.A.
Varicocele, Pelvic Congestion Syndrome
Evaluation of PerformanCe of the Peripheral EOS in the Treatment of Varicocele or Pelvic Congestion SynDromE
To collect confirmatory data in support of the safety and performance of the ArtVentive Medical Group Endoluminal Occlusion System.
- Trial name
- OCCLUDE-I (NCT02033863)
- Where
- 3 sites in Belgium, Poland and 1 more
- Volunteers
- 40 people
- Sponsor
- ArtVentive Medical Group, Inc.
Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome (CPPS)
Vaginal Photobiomodulation for Chronic Pelvic Pain
The goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women.
- Trial name
- VOICE (NCT06673108)
- Testing
- SoLa Pelvic Therapy
- Where
- 11 sites in United States
- Volunteers
- 128 people
- Sponsor
- SoLa Pelvic Therapy
Chronic Prostatitis, Chronic Pelvic Pain Syndrome
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
This is a randomized, multi-center, double-blind, parallel-group study, enrolling approximately 100 male subjects diagnosed with CP/CPPS to evaluate the effect of 12-week treatment with AQX-1125 (active drug) compared to placebo.
- Trial name
- CP/CPPS (NCT03500159)
- Testing
- AQX-1125 200 mg
- Where
- 27 sites in United States, Canada
- Volunteers
- 3 people
- Sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
Chronic Prostatitis
Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS
Clinical trial title：Efficacy and safety of Ningmitai capsule alone or combined with celecoxib in the treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A prospective, randomized, double-blind, multicenter…
- Trial name
- NCT06159114
- Testing
- Ningmitai capsule, Celecoxib capsule
- Where
- China
- Volunteers
- 242 people
- Sponsor
- Xintian Pharmaceutical
Chronic Prostatitis With Chronic Pelvic Pain Syndrome
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis
The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.
- Trial name
- NCT00826514
- Testing
- Tanezumab
- Where
- 44 sites in United States, Canada and 3 more
- Volunteers
- 62 people
- Sponsor
- Pfizer
Chronic Abacterial Prostatitis, Chronic Pelvic Pain Syndrome
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
In this study several doses of ASP3652, given orally for 12 weeks, will be compared with placebo in the treatment of patients with Chronic abacterial Prostatitis / Chronic Pelvic Pain Syndrome.
- Trial name
- AZURE (NCT01391338)
- Testing
- ASP3652
- Where
- 49 sites in Czechia, Germany and 4 more
- Volunteers
- 239 people
- Sponsor
- Astellas Pharma Inc
Pelvic Floor Disorders, Pelvic Pain
Digital Care Programs for Female Pelvic Health
The purpose of this study is to create a research repository, composed of data collected in the course of digital care programs for pelvic health conditions by SWORD Health/Bloom to individuals undergoing those programs.
- Conditions
- Pelvic Floor Disorders, Pelvic Pain, Pelvic Organ Prolapse, Pelvic Floor Muscle Weakness
- Trial name
- NCT05513417
- Testing
- Bloom Pod
- Where
- United States
- Volunteers
- 50,000 people, healthy volunteers welcome
- Sponsor
- Sword Health, SA